https://doi.org/10.1016/s1474-4422(17)30369-1
T
Tomihiro Imai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
145
Papers
3.3K
Citations
25
h-index
55
i10-index
Tomihiro Imai is an academic researcher from Transitional Learning Center. The author has contributed to research in topics: Myasthenia Gravis and Thymoma & Peripheral Neuropathies and Disorders & Parkinson's Disease and Spinal Disorders. The author has an h-index of 25, co-authored 124 publications.
ORCID: 0000-0002-3601-0564Papers by this author
worksSafety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2017 · The Lancet Neurology · 764 citations
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2021 · The Lancet Neurology · 612 citations
https://doi.org/10.1016/s1474-4422(21)00159-9
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis
2020 · Clinical & Experimental Immunology · 134 citations
https://doi.org/10.1111/cei.13546
A new method to evaluate staircase phenomenon in skeletal muscle using piezoelectric sensor
2024 · Clinical Neurophysiology Practice · 2 citations
https://doi.org/10.1016/j.cnp.2024.12.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat